Muscle antibodies in myasthenic mothers and their babies. (Q54737395)

3 June 2018

title

Muscle antibodies in myasthenic mothers and their babies. (English)

1 reference

3 June 2018

1 reference

H J Oosterhuis

1

1 reference

3 June 2018

T E Feltkamp

series ordinal

2

1 reference

3 June 2018

H R van der Geld

series ordinal

3

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 December 1966

1 reference

3 June 2018

published in

The Lancet

1 reference

3 June 2018

volume

2

1 reference

3 June 2018

issue

7475

1 reference

3 June 2018

page(s)

1226-1227

1 reference

3 June 2018

MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Myasthenia gravis. Immunological relationship between striated muscle and thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Immunological concomitants of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Studies in myasthenia gravis. Correlation of antibody immunofluorescence with clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

[Contribution to the immunopathology of myasthenia gravis]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

NEONATAL MYASTHENIA GRAVIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

ON THE PHYSIOLOGY AND PATHOPHYSIOLOGY OF NEUROMUSCULAR TRANSMISSION OF STIMULATION IN THE NEWBORN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Immunity in the foetus and the new-born

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Effects of the hyperglycemic-glycogenolytic factor (HGF), epinephrine and insulin in normal and depancreatized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Secretion of the hyperglycemic-glycogenolytic factor in normal dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Effect of diethyldithiocarbamate and other agents on mice with the obese-hyperglycemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

High levels of pancreatic insulin coexistent with hyperplasia and degranulation of beta cells in mice with the hereditary obese-hyperglycemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Comparison of plasma insulin levels following administration of tolbutamide and glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

The effect of epinephrine on immunoreactive insulin levels in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

PROMOTION OF INSULIN SECRETION BY GLUCAGON

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992306-3

7 January 2021

10.1016/S0140-6736(66)92306-3

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018